This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics Scientific Forum
See You Next Year! 26-28 Feb, 2025
Westin Miyako KyotoKyoto, Japan

Ryuji Hayashi, PhD
Group Head, Discovery Chemistry Department, Research Division at Chugai Pharmaceutical Co., Ltd.


Ryuji earned his Ph.D. in organic chemistry from North Dakota State University. After postdoctoral training at the University of Wisconsin-Madison, he joined Chugai Pharmaceutical. He is currently a group head of discovery chemistry department at Chugai Pharmaceutical and managing number of drug discovery projects associated with macrocyclic peptides.

Agenda Sessions

  • Development of Orally Bioavailable Peptides Targeting an Intra-cellular Protein: From a Hit to a Clinical KRAS Inhibitor